ResoTher Pharma is pleased to announce the appointment of Teis Vester, MSc., as Chief Financial Officer as of today, August 16th, 2021. Teis will report to Lone Veng, CEO, and replaces co-founder Jeppe Øvlesen, who remains in the company as a member of the Board of Directors.
“We are very pleased to welcome Teis to our leadership team to support the further development of ResoTher Pharma” stated Lone Veng. “Teis has solid experience with both strategic and operational financial management from his many years in various financial advisory roles and within group finance positions in both listed companies and in privately‐owned biotech. I am confident that Teis will be an excellent addition to our leadership team and I look forward to working with him on this next leg of our journey into clinical development and together taking our company to the next level”.